REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC ...
XCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, and Rosebud ...
Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies across immuno-oncology and regenerative medicine. The company announced the launch of ...
Explore scalable strategies for iPSC-derived islet differentiation using GMP-grade activin A and KGF to advance diabetes ...
Zacks Investment Research on MSN
Century Therapeutics (IPSC) upgraded to strong buy: Here's what you should know
Century Therapeutics, Inc. (IPSC) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...
Designation underscores the potential of this chemically induced, off-the-shelf cell therapy to address a high unmet need in ...
Alongside the complete kit, TheWell Bioscience has released the RocketCell (TM) iPSC Xeno-Free Growth Medium. Available as a standalone product, this xeno-free medium is designed for researchers who ...
Organoids are an important component of translational research, particularly for evaluating drug toxicity and tissue-specific responses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results